Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
about
Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-Induced Neuropathy in Cancer Survivors.Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.Peripheral neuropathy in prediabetes and the metabolic syndrome.Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular BioenergeticsMuscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.Long-term peripheral neuropathy symptoms in breast cancer survivors.Falls in older adults with multiple myeloma.Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.Long-Term and Latent Side Effects of Specific Cancer Types.Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.Living with chronic pain: perceptions of breast cancer survivors.Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).Falls and Physical Inactivity in Patients with Gastrointestinal Cancer and Hand-Foot Syndrome.Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations
P2860
Q37662576-26C13AEE-0F32-49D1-9403-32B71A1304C3Q38740918-B0521029-1969-45E5-97CE-42A2E2454A60Q38773529-182729F3-F0D3-4E33-A7A3-05AF66A9D633Q39138091-F310DB97-5500-4F02-A4D3-42C0B8802DD6Q39165929-FFAA516A-F903-4D6B-BF49-6E22DDA3B599Q39374624-42820830-75F8-48FE-98CF-F97D44802336Q44751659-7F5CEE9A-7FE1-4C8E-90C5-5A3F3D87AF0EQ47217006-5B2CFD8A-3BAD-48D3-9402-BE8E42826414Q47265300-A03BA076-92E9-4A24-9B16-A5B744F45365Q47313009-30039D1B-7C5B-43C7-8CD5-60928728CE66Q47550985-86E153C6-E4D2-47AA-824F-E9422A7A83E4Q47564629-7963F3AC-175A-429D-952F-113693FF55A3Q47602301-4C0B1EBD-E8CE-47B6-A40A-AE4491287567Q47805054-B0C0933B-45A3-4BD5-B06B-BB7BD31F25E5Q48209604-9EFE2C73-2040-44BD-9641-7A7A0A467EC3Q50035155-BADCE914-0CB9-40E9-8FDE-9B863CDCD9B2Q50089791-7D0E8097-DC25-4F04-BABE-E49EC09F65EFQ55411619-64F735BB-50A4-4864-9E64-B31A7DB8D8D0Q57167257-6A97B485-D754-477D-AC28-BEB4FE0886FF
P2860
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-term chemotherapy-induced ...... e, risk factors, and fall risk
@en
type
label
Long-term chemotherapy-induced ...... e, risk factors, and fall risk
@en
prefLabel
Long-term chemotherapy-induced ...... e, risk factors, and fall risk
@en
P2093
P2860
P1476
Long-term chemotherapy-induced ...... e, risk factors, and fall risk
@en
P2093
Andrew D Seidman
Christina Seluzicki
Coby Basal
Susan Q Li
P2860
P2888
P304
P356
10.1007/S10549-016-3939-0
P407
P50
P577
2016-08-10T00:00:00Z
P6179
1018427424